Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

It Is Not Just the Royals Who Go Through Cancer.

2.

Have the Harms of Lung Cancer Screening Been Exaggerated?

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

Novel Agent for Chronic GVHD Wins FDA Approval

5.

Rising rates of head and neck cancers in England


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot